Affiliation: Stanford University
- A randomized, double-blind, placebo-controlled trial of augmentation topiramate for chronic combat-related posttraumatic stress disorderSteven E Lindley
Department of Psychiatry, Stanford University School of Medicine, Stanford, CA, USA
J Clin Psychopharmacol 27:677-81. 2007..The present study was designed as a test of topiramate's efficacy as adjunctive therapy in a 7-week, randomized, double-blind, placebo-controlled trial...
- Monitoring mental health treatment acceptance and initial treatment adherence in veterans: veterans of Operations Enduring Freedom and Iraqi Freedom versus other veterans of other erasSteven Lindley
Department of Psychiatry, Stanford University School of Medicine, Stanford, California, USA
Ann N Y Acad Sci 1208:104-13. 2010..No variables predicted OEF/OIF acceptance/attendance. In conclusion, our findings illustrate the importance of close, continual monitoring of clinical process data to help reveal targets for improving mental health care for veterans...
- Glucocorticoid antagonists in neuropsychiatric [corrected] disordersAlan F Schatzberg
Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, United States
Eur J Pharmacol 583:358-64. 2008..g., Alzheimer's disease and mild cognitive impairment), cognitive side effects of electroconvulsive therapy, and weight gain with atypical antipsychotic agents. Potential benefits and limitations are discussed...
- Relationship between body mass index and insulin resistance in patients treated with second generation antipsychotic agentsSun H Kim
Department of Medicine, 300 Pasteur Drive, S025, Stanford, CA 94305 5103, USA
J Psychiatr Res 44:493-8. 2010..Olanzapine also appears to have an independent effect on insulin resistance that is above and beyond obesity...
- Mesotelencephalic dopamine neurochemical responses to glucocorticoid administration and adrenalectomy in Fischer 344 and Lewis ratsSteven E Lindley
National Center for PTSD, Department of Veterans Affairs, Palo Alto Health Care Systema, PTSD 352 117, 795 Willow Road, Menlo Park, CA 94025, USA
Brain Res 958:414-22. 2002..The findings indicate a pattern of changes in neurochemical measurements consistent with a small magnitude inhibition of basal dopamine metabolism, but not with a change neuronal activity, release or reuptake...
- Basal and dexamethasone suppressed salivary cortisol concentrations in a community sample of patients with posttraumatic stress disorderSteven E Lindley
Department of Veterans Affairs, National Center for Posttraumatic Stress Disorder, Palo Alto Veterans Affairs Health Care System, Menlo Park, California 94025, USA
Biol Psychiatry 55:940-5. 2004....
- Monoamine oxidase and catechol-o-methyltransferase enzyme activity and gene expression in response to sustained glucocorticoidsSteven E Lindley
Department of Psychiatry, Veterans Affairs Palo Alto Health Care System, CA 94304, USA
Psychoneuroendocrinology 30:785-90. 2005..The results do not support inhibition of DA metabolism as a mechanism by which glucocorticoids influence DA-mediated behaviors...
- No improvement of posttraumatic stress disorder symptoms with guanfacine treatmentThomas C Neylan
Department of Psychiatry, University of California, San Francisco, USA
Am J Psychiatry 163:2186-8. 2006..The authors report an 8-week, double-blind, randomized controlled trial of guanfacine versus placebo for posttraumatic stress disorder (PTSD)...
- Early life stress and novelty seeking behavior in adolescent monkeysKaren J Parker
Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, 1201 Welch Road, MSLS Room P104, Mail Code 5485, Stanford, CA 94305 5485, USA
Psychoneuroendocrinology 32:785-92. 2007..These trait-like differences in novelty seeking appear to reflect mild early stress-induced adaptations that enhance curiosity and resilience...